Temprian Oncology Inc.
PrivateLast Round
Seed
Aug 1, 2024
Total Funding Raised
$575,000
Company Overview
Temprian Oncology Inc. is a biotechnology company developing highly selective nanoparticle-based supercarriers for the treatment of advanced melanoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Temprian Oncology Inc. Comparables
Compare Temprian Oncology Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saros Therapeutics | 79% | |
| Flashpoint Therapeutics | 77% | |
| NanoVax Therapeutics | 74% |
Temprian Oncology Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2024 | ||||
| Grant | Dec 1, 2023 |
Key People
Founding team and executive leadership
Temprian Oncology Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2Flo Ventures | Seed |
| National Science Foundation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors grew 436% MoM, from 122 to 654.
- Aug 1, 2024
$300K round from National Science Foundation
Temprian Oncology Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Temprian Oncology Inc.'s valuation, stock price, and market status.
Is Temprian Oncology Inc. a public or private company?
Temprian Oncology Inc. is a private company.
What is the current stock price of Temprian Oncology Inc.?
Temprian Oncology Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Temprian Oncology Inc. worth (valuation)?
Valuation information for Temprian Oncology Inc. is not publicly available.
Can I buy Temprian Oncology Inc. stock?
Temprian Oncology Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Temprian Oncology Inc.'s last funding round?
Temprian Oncology Inc.'s most recent funding round was Seed on August 1, 2024.
Who are the main investors in Temprian Oncology Inc.?
Key investors in Temprian Oncology Inc. include National Science Foundation.
Will Temprian Oncology Inc. IPO soon?
No public IPO plans have been announced for Temprian Oncology Inc..
How can I track Temprian Oncology Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Temprian Oncology Inc.'s secondary market activity and sign up for updates.